John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LTC
1401
LTC Properties
LTC
$2.17B
| $1.75M | 0.01% |
+45,574
| New | +$1.61M |
|
1402
Horizon Bancorp
HBNC
$1.01B
| $1.75M | 0.01% |
93,636
-16,743
| -15% | -$347K |
|
|
VTNR
1403
DELISTED
Vertex Energy, Inc
VTNR
| $1.75M | 0.01% |
+175,825
| New | +$1.07M |
|
1404
The Bancorp
TBBK
$2.7B
| $1.75M | 0.01% |
61,653
+14,593
| +31% | +$420K |
|
1405
Alarm.com
ALRM
$2.81B
| $1.75M | 0.01% |
26,272
+17,972
| +217% | +$1.27M |
|
1406
Ezcorp Inc
EZPW
$2.16B
| $1.75M | 0.01% |
289,057
+30,306
| +12% | +$189K |
|
|
RAPT
1407
DELISTED
RAPT Therapeutics
RAPT
| $1.73M | 0.01% |
9,849
-7,341
| -43% | -$1.39M |
|
1408
Primoris Services
PRIM
$4.17B
| $1.73M | 0.01% |
72,678
-22,747
| -24% | -$586K |
|
|
NXGN
1409
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.72M | 0.01% |
82,402
-75,636
| -48% | -$1.45M |
|
|
BWIN
1410
Baldwin Insurance Group
BWIN
$3.02B
| $1.72M | 0.01% |
64,008
+26,931
| +73% | +$776K |
|
1411
Wheels Up
UP
$186M
| $1.71M | 0.01% |
2,753
+1,798
| +188% | +$1.3M |
|
1412
Wynn Resorts
WYNN
$10.2B
| $1.71M | 0.01% |
21,482
-718,683
| -97% | -$60.6M |
|
1413
Astronics
ATRO
$3.28B
| $1.71M | 0.01% |
158,820
+91,333
| +135% | +$993K |
|
1414
US Physical Therapy
USPH
$1.15B
| $1.71M | 0.01% |
17,177
-7,871
| -31% | -$751K |
|
1415
Kopin
KOPN
$909M
| $1.71M | 0.01% |
674,664
-228,949
| -25% | -$659K |
|
1416
Oric Pharmaceuticals
ORIC
$1.43B
| $1.71M | 0.01% |
+319,355
| New | +$2.88M |
|
|
CYBE
1417
DELISTED
Cyberoptics Corp
CYBE
| $1.7M | 0.01% |
41,776
-8,882
| -18% | -$341K |
|
1418
Hackett Group
HCKT
$276M
| $1.69M | 0.01% |
73,272
+7,950
| +12% | +$162K |
|
1419
Itron
ITRI
$4.34B
| $1.69M | 0.01% |
+32,018
| New | +$1.79M |
|
1420
Red Rock Resorts
RRR
$3.57B
| $1.69M | 0.01% |
+34,700
| New | +$1.65M |
|
1421
Evolution Petroleum
EPM
$126M
| $1.68M | 0.01% |
248,020
+117,013
| +89% | +$752K |
|
1422
HEICO Corp
HEI
$49.9B
| $1.68M | 0.01% |
10,967
-159,363
| -94% | -$23.1M |
|
1423
Cal-Maine
CALM
$3.91B
| $1.67M | ﹤0.01% |
+30,293
| New | +$1.32M |
|
|
GDSTU
1424
DELISTED
Goldenstone Acquisition Limited Units
GDSTU
| $1.67M | ﹤0.01% |
+166,664
| New | +$1.67M |
|
|
FTIIU
1425
DELISTED
FutureTech II Acquisition Corp. Unit
FTIIU
| $1.67M | ﹤0.01% |
+166,666
| New | +$1.67M |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.